Literature DB >> 9032329

Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax.

I Lemasson1, V Robert-Hebmann, S Hamaia, M Duc Dodon, L Gazzolo, C Devaux.   

Abstract

To understand the mechanism of p56lck protein downregulation observed in human T cells infected by human T-cell leukemia virus type 1 (HTLV-1), we have investigated the ability of the 3' end of the HTLV-1 genome as well as that of the tax and rex genes to modulate p56lck protein expression and p56lck mRNA synthesis. By using Jurkat T cells stably transfected with constructs that expressed either the 3' end of the HTLV-1 genome (JK C11-pMTEX), the tax gene (JK52-Tax) or the rex gene (JK9-Rex), we found that the expression of p40tax (Tax) was sufficient to modulate p56lck protein expression. Similarly, we found that the expression of the mRNA which encoded p56lck was repressed in Jurkat T cells which expressed Tax. This downregulation was shown to be proportional to the amount of tax mRNA found in the transfected cells, as evidenced by experiments that used cells (JPX-9) stably transfected with a tax gene driven by a cadmium-inducible promoter. Furthermore, cadmium induction of Tax in JPX-9 cells transiently transfected with a construct containing the chloramphenicol acetyltransferase (CAT) gene under control of the lck distal promoter (lck DP-CAT) resulted in the downregulation of CAT gene expression. In contrast, cadmium induction of Tax in JPX-9 cells transiently transfected with a CAT construct driven by a lck DP with a deletion extending from position -259 to -253 (a sequence corresponding to a putative E-Box) did not modulate CAT gene expression, suggesting that the effect of Tax on p56lck is mediated through an E-Box binding protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032329      PMCID: PMC191281     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats.

Authors:  B K Felber; H Paskalis; C Kleinman-Ewing; F Wong-Staal; G N Pavlakis
Journal:  Science       Date:  1985-08-16       Impact factor: 47.728

2.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

3.  Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice.

Authors:  L Feigenbaum; K Fujita; F S Collins; G Jay
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein.

Authors:  M N Uittenbogaard; H A Giebler; D Reisman; J K Nyborg
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

5.  Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein.

Authors:  I J Koralnik; J C Mulloy; T Andresson; J Fullen; G Franchini
Journal:  J Gen Virol       Date:  1995-08       Impact factor: 3.891

6.  Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I.

Authors:  S Z Salahuddin; P D Markham; S G Lindner; J Gootenberg; M Popovic; H Hemmi; P S Sarin; R C Gallo
Journal:  Science       Date:  1984-02-17       Impact factor: 47.728

7.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

8.  A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.

Authors:  M P Kamps; C Murre; X H Sun; D Baltimore
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

9.  Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator.

Authors:  M Seiki; J Inoue; T Takeda; M Yoshida
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

10.  The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells.

Authors:  M Benkirane; K T Jeang; C Devaux
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more
  25 in total

Review 1.  Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.

Authors:  Gerold Feuer; Patrick L Green
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  The human T-cell leukemia virus type 1 Rex regulatory protein exhibits an impaired functionality in human lymphoblastoid Jurkat T cells.

Authors:  S Hamaia; H Cassé; L Gazzolo; M Duc Dodon
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein.

Authors:  H Valentin; I Lemasson; S Hamaia; H Cassé; S König; C Devaux; L Gazzolo
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 4.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

5.  Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression.

Authors:  Adam Tripp; Prabal Banerjee; Michelle Sieburg; Vicente Planelles; Fengzhi Li; Gerold Feuer
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  CREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein.

Authors:  K V Kibler; K T Jeang
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 7.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 8.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

9.  Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1.

Authors:  Shiwen Jiang; Takefumi Inada; Masakazu Tanaka; Rika A Furuta; Koh Shingu; Jun-ichi Fujisawa
Journal:  Retrovirology       Date:  2009-08-11       Impact factor: 4.602

Review 10.  Hematopoietic stem cells and retroviral infection.

Authors:  Prabal Banerjee; Lindsey Crawford; Elizabeth Samuelson; Gerold Feuer
Journal:  Retrovirology       Date:  2010-02-04       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.